Dr. John A. Kosteva, MD

  • Berwyn, PA
  • Hematologist and oncologist
NPI1700036902PAC ID9133271737
Medicare services, 2024
1,870
Medicare patients, 2024
361
Part D claims, 2024
843
Publications
7
MIPS score, 2024
85
Practice address
1001 Chesterbrook Blvd, Berwyn, PA 19312
Practice phone
Call (215) 615-5858
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Perelman Center for Advanced Medicine

Berwyn, Pennsylvania

See all 10 affiliations

Find Dr. Kosteva's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. John A. Kosteva is a hematologist and oncologist in Berwyn, Pennsylvania

Dr. Kosteva practices at Perelman Center for Advanced Medicine in Berwyn, Pennsylvania.

Dr. Kosteva's NPI, 1700036902, was assigned on September 24, 2008. Dr. Kosteva graduated from Temple University School of Medicine in 2002. Dr. Kosteva holds Pennsylvania license MD426127.

NPI and contact details
Medicare PAC ID
9133271737
NPI enumeration date
September 24, 2008
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(215) 615-5858
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
50
Medical school graduation
2002

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. John A. Kosteva practices at Perelman Center for Advanced Medicine in Berwyn, Pennsylvania

Dr. Kosteva's primary practice is Perelman Center for Advanced Medicine, at 1001 Chesterbrook Blvd, Berwyn, PA 19312 in Chester County. The practice phone is (215) 615-5858.

  • Perelman Center for Advanced Medicine
    1001 Chesterbrook Blvd, Berwyn, PA 19312 · Chester CountyPhone(215) 615-5858

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. John A. Kosteva is affiliated with 8 sites of care and 2 medical groups

Dr. Kosteva's primary practice is Perelman Center for Advanced Medicine in Berwyn, Pennsylvania. Dr. Kosteva is also affiliated with Hospital of the University of Pennsylvania. The medical group on file is Penn Medicine Lancaster General Health. Dmand AI also links Dr. Kosteva to 3 more hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

See all 10 affiliations for Dr. Kosteva

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. John A. Kosteva's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kosteva practices, 7 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Perelman Center for Advanced MedicineAvailable with a free account
+7 more sites and 1 medical groupAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Kosteva practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. John A. Kosteva is one of 645 hematologists and oncologists in Pennsylvania

Hematology and oncology is Dr. Kosteva's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Kosteva's licenses on file in 2 states: Pennsylvania and New Jersey.

Specialties and state licenses

  • Hematology and oncology, PennsylvaniaPrimaryLicense MD426127 · taxonomy 207RH0003X
  • New Jersey licenseLicense 25MA08581700

Hematologists and oncologists near Dr. Kosteva

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

645hematologists and oncologists in Pennsylvania
2hematologists and oncologists in Berwyn

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. John A. Kosteva billed Medicare for 1,870 services in 2024

CMS data shows 1,870 Medicare services from Dr. Kosteva across 6 procedure codes in 2024, for 361 Medicare patients. Medicare paid $104,532 for them. Every service was in an office.

Medicare services, 20241,870
Medicare patients361
Paid by Medicare$104,532
Procedure codes6

Dr. Kosteva's Medicare services by type, 2023 to 2024

  • 2023
  • 2024
Office and hospital visits
2023: 1,0652024: 1,0422%
Other services
2023: 02024: 828

Dr. Kosteva compared with the Pennsylvania median for hematologists and oncologists, 2024

  • Dr. Kosteva
  • Pennsylvania median
Medicare services
1,870vs 6542.9 times
Medicare patients
361vs 22759% above
Part D claims
605vs 39354% above

Medians across 600 hematologists and oncologists in Pennsylvania with Dmand AI profiles that report each measure.

Dr. Kosteva's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Kosteva

Need commercial claims for Dr. Kosteva?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Kosteva and other hematologists and oncologists in Pennsylvania.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. John A. Kosteva treated 361 Medicare patients in 2024, average age 74

CMS counts 361 Medicare patients who saw Dr. Kosteva in 2024. The largest group is 65 to 74, with 184 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kosteva's median patient age at 74, with 46% women.

Medicare patients, 2024361
Average age74
Average risk score2.18
Also on Medicaid5%

Dr. Kosteva's Medicare patients by age, 2024

Dr. Kosteva's Medicare patients by sex, 2024

  • Women16445%
  • Men19755%

Chronic conditions among Dr. Kosteva's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol75%
  3. Cancer58%
  4. Arthritis40%
  5. Ischemic heart disease39%
  6. Diabetes29%
  7. Anxiety27%
  8. Chronic kidney disease24%

Share of Medicare patients with each condition. A patient can have several.

Dr. Kosteva's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 74

Patient panel by sex, all payers

  • Women46%
  • Men53%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. John A. Kosteva wrote 843 Medicare Part D claims in 2024

In 2024, Dr. Kosteva wrote 843 Medicare Part D claims for 161 patients. 60% of them were for generic drugs. CMS names the drug for 605 of them, across 24 drugs with 11 or more claims each, at $2,307,361 in total drug cost. In 2023, CMS named 513 claims across 21 drugs.

Part D claims, 2024843
Drugs named by CMS24
Total drug cost$2.3M
Part D patients161

Dr. Kosteva's Part D claims by kind of drug, 2024

  • Generic505 claims60%
  • Brand-name338 claims40%

Dr. Kosteva's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Kosteva's Part D claims, 2024

  • Opioids4%37 of 843 claims
  • Antibiotics2%15 of 843 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 5132024: 60518%

Drugs named by CMS: 24 in 2024, 21 in 2023.

See all prescribing by Dr. Kosteva

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. John A. Kosteva scored 85 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Kosteva for performance year 2024, reported as part of a group. Dr. Kosteva accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Dr. Kosteva's MIPS scores, performance year 2024

  • 85of 100Final score
  • 73.6of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 76of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Kosteva by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. John A. Kosteva has 7 publications on record

Dmand AI links 7 papers to Dr. Kosteva, published from 2016 to 2024. 2023 was the busiest year, with 2. The most frequent topics are Carcinoma, Non-Small-Cell Lung, Lung Neoplasms and Antibodies, Monoclonal. Dr. Kosteva has published most often in Clin Lung Cancer. Dr. Kosteva's most frequent co-authors are Charu Aggarwal, MD, MPH, Christine Agnes Ciunci, MD and Corey J. Langer, MD.

Papers7
Years published2016 to 2024

Dr. Kosteva's papers by year, 2016 to 2024

Topics Dr. Kosteva writes about most

  • Carcinoma, Non-Small-Cell Lung
  • Lung Neoplasms
  • Antibodies, Monoclonal
  • Chemoradiotherapy
  • Genotype

Dr. Kosteva's most frequent co-authors

Recent publications by Dr. Kosteva

See all 7 publications and co-authors

See who Dr. Kosteva researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Kosteva works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. John A. Kosteva received $40,616 in industry payments from 2016 to 2025

CMS Open Payments shows 52 general payments to Dr. Kosteva from 11 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 79% of the total. AstraZeneca Pharmaceuticals LP paid the most, $15,205.

General payments to Dr. Kosteva by program year, 2016 to 2025

General payments to Dr. Kosteva by kind, 2016 to 2025

$40.6Kin total
  • Consulting fees$31,98679%
  • Travel and lodging$3,3018%
  • Speaker and faculty fees$2,4506%
  • Honoraria$1,5004%
  • Other$1,3803%

Companies that paid Dr. Kosteva the most, 2016 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Kosteva

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. John A. Kosteva graduated from Temple University School of Medicine

Dr. Kosteva graduated from Temple University School of Medicine in 2002.

  1. Medical schoolTemple University School of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. John A. Kosteva's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. John A. Kosteva

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. John A. Kosteva's NPI number?

Dr. John A. Kosteva's NPI number is 1700036902. It was assigned on September 24, 2008, and it is active in the NPI Registry.

What kind of doctor is Dr. John A. Kosteva?

Dr. John A. Kosteva is a hematologist and oncologist in Berwyn, Pennsylvania. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. John A. Kosteva practice?

Dr. Kosteva practices at 1001 Chesterbrook Blvd, Berwyn, PA 19312. Dr. Kosteva's primary practice is Perelman Center for Advanced Medicine in Berwyn, Pennsylvania. Dmand AI also links Dr. Kosteva to 3 hospitals, 2 group practices and clinics, 1 home health agency and 1 medical group.

What is Dr. John A. Kosteva's office phone number?

The practice phone on file for Dr. Kosteva is (215) 615-5858.

What is Dr. John A. Kosteva's medical license number?

Dr. Kosteva holds Pennsylvania license MD426127, one of the licenses on file in 2 states.

Which states has Dr. John A. Kosteva been licensed in?

Dmand AI has state licenses on file for Dr. Kosteva in Pennsylvania and New Jersey.

Which hospitals is Dr. John A. Kosteva affiliated with?

Dr. Kosteva is affiliated with Hospital of the University of Pennsylvania. Dmand AI links Dr. Kosteva to 3 more hospitals.

What medical group is Dr. John A. Kosteva part of?

Dr. Kosteva is linked to Penn Medicine Lancaster General Health. Dmand AI links Dr. Kosteva to 1 more medical group.

Does Dr. John A. Kosteva accept Medicare?

Yes. CMS data shows Dr. Kosteva billed Medicare for 1,870 services in 2024, and Dr. Kosteva accepts Medicare assignment.

What is Dr. John A. Kosteva's MIPS score?

Dr. Kosteva's MIPS final score for performance year 2024 is 85 out of 100, reported as part of a group.

Show 8 more questionsShow fewer questions

How many Medicare patients does Dr. John A. Kosteva see?

CMS counts 361 Medicare patients who saw Dr. Kosteva in 2024, with an average age of 74.

What services does Dr. John A. Kosteva bill to Medicare?

In 2024, Dr. Kosteva's most billed Medicare services were medicare service (G2211), office visit, established patient (99214) and office visit, established patient (99215).

Where did Dr. John A. Kosteva go to medical school?

Dr. Kosteva graduated from Temple University School of Medicine in 2002.

What drugs does Dr. John A. Kosteva prescribe most?

In 2024 Medicare Part D data, Dr. Kosteva's most prescribed drugs by claims were Ondansetron HCl, Tagrisso and Eliquis.

Has Dr. John A. Kosteva received payments from drug or device companies?

CMS Open Payments shows $40,616 in general payments to Dr. Kosteva from 11 companies from 2016 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. John A. Kosteva been practicing?

Dr. Kosteva graduated from medical school in 2002, 24 years ago.

Does Dr. John A. Kosteva do research?

Dmand AI links 7 publications to Dr. Kosteva, published from 2016 to 2024.

Who does Dr. John A. Kosteva publish with?

Dr. Kosteva's most frequent co-authors are Charu Aggarwal, MD, MPH (7 shared papers), Christine Agnes Ciunci, MD (5 shared papers) and Corey J. Langer, MD (5 shared papers).

Selling to hematology and oncology practices?

See hematologists and oncologists in Pennsylvania by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)